Browse by category

First patient enrolled in a Phase 2 Study in T2DM patients with Olatec's NLRP3 inhibitor dapansutrile

The first patient with T2DM and diabetes-related complications has been enrolled in the clinical trial, DAPAN-DIA, in Basel, Switzerland,...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

4 hours ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

5 hours ago

Racial and ethnic groups face barriers to obtaining OMMs

6 hours ago

Weekly Digest